Glonghui December 15: Some investors asked Jianfan Biotech (300529.SZ) on the investor interactive platform, “How is the progress of the company's dialyzer production line? Can dialysis membranes be produced, and polyether wire drawing technology is available?” The company replied, “(1) The company currently has two hemodialyzer production lines and has mass production capacity. The company's homemade membrane material is polyethersulfone, which is currently in the R&D registration stage. (2) In September 2023, the company was selected as a finalist for the first batch of biomedical materials innovation tasks by the Ministry of Industry and Information Technology. It is the only unit in Guangdong Province to be shortlisted for the development of medical polyethersulfone polymer materials. The work to unveil the biomedical materials innovation task list was carried out jointly by two departments of the Ministry of Industry and Information Technology and the State Drug Administration to select a group of units that have mastered key core technologies and strong innovative capabilities to focus on research and achieve key breakthroughs in some iconic biomedical materials fields. The implementation of the company's medical polyethersulfone project will help promote upstream and downstream collaborative innovation in biomedical materials and better support the high-quality development of China's medical device industry.